Clinical Trials Browser

Phase 2 × INDUSTRY × Dapsone × Clear all

NCT00343187 2011-05-30

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Exanthema